Cholera: Assessing the risk to travellers and identifying methods of protection

Travel Medicine and Infectious Disease

Volumn 1, Issue 2, 2003, Pages 80-88

  Steffen, Robert ^a   Acar, Jacques ^b   Walker, Eric ^c   Zuckerman, Jane ^d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b SORBONNE UNIVERSITÉ   (France)

^c Scottish Centre for Infection and Environmental Health   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cholera; Dukoral ; Travel health; Travel medicine; Traveller's diarrhoea; Vaccination

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIMALARIAL AGENT; BETA LACTAM ANTIBIOTIC; BICARBONATE; CHLORAMPHENICOL; CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; DRINKING WATER; ELECTROLYTE; INACTIVATED VIRUS VACCINE; LIVE VACCINE; LOPERAMIDE; ORAL REHYDRATION SOLUTION; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFATRIMETHOPRIM; TETRACYCLINE;

ARTERY OCCLUSION; BACTERIAL TRANSMISSION; CHOLERA; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CONSULTATION; DEHYDRATION; DEVELOPING COUNTRY; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; EUROPEAN AMERICAN; EVIDENCE BASED MEDICINE; FATALITY; FOOD INTAKE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; HEALTH CARE PLANNING; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; HYPOVOLEMIA; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTERPERSONAL COMMUNICATION; KIDNEY FAILURE; LUNG EDEMA; METABOLIC ACIDOSIS; MORBIDITY; NONHUMAN; ORAL REHYDRATION THERAPY; PAIN; PREMATURITY; PRIORITY JOURNAL; RECOGNITION; REVIEW; RISK ASSESSMENT; SANITATION; SEPTIC SHOCK; SIDE EFFECT; SPONTANEOUS ABORTION; SYMPTOM; TRAVEL; VIBRIO CHOLERAE; WORLD HEALTH ORGANIZATION;

EID: 15944398285     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1477-8939(03)00062-0     Document Type: Article

References (54)

1. WHO, Cholera, 2001. Wkly Epidemiol Rec 2002;77(31):257-68.
2. WHO, Cholera vaccines. WHO position paper. Wkly Epidemiol Rec 2001;76(16):117-24.
3. CDC/NCID, Laboratory methods for the diagnosis of epidemic dysentery abd cholera. Atlanta 1999;37-40.
4. Sack D, Cadoz M. Cholera vaccines. In: Plotkin SA, Orenstein WA, editors. Vaccines. Philadephia: W. B. Saunders Company; 1999. p. 639-49.
5. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981;292(5822):413-7.
6. Holmgren J, Jertborn M, Svennerholm A. New and improved vaccines against cholera. In: Levine MM, et al., editors. New generation vaccines. New york: Marcel Dekker; 1997. p. 459-68.
7. WHO, WHO report on global surveillance of epidemic-prone infectious diseases. Cholera, Geneva: WHO; 2000. Chapter 4, pp 39-43.
8. Goma Epidemiology Group, Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Lancet 1995;345(8946):339-44.
9. WHO, Cholera Fact Sheet, http://www.who.int/inf-fs/en/fact107.html, 2000.
10. WHO, Potential use of oral cholera vaccines in emergency situations: Report of a WHO meeting, 12-13 May 1999, www.who.int/emc, World Health Organisation, 1999.
11. Siddique AK, et al. Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res 1992;10(2):79-86.
12. WHO, Cholera in 1991. Wkly Epidemiol Rec 1992;67:253-60.
13. WHO, Cholera Reporting: International Health regulations, http://www.who.int/csr/disease/cholera/ihrnotification/en/, 2003.
14. WHO, Cholera in Iraq-Update, http://www.who.int/csr/don/2003_05_14/en/, 2003.
15. WHO, Cholera in Iraq, http://www.who.int/csr/don/2003_05_08a/en/, 2003.
16. WHO, Cholera in Iraq-Update, http://www.who.int/csr/don/2003_05_13a/en/, 2003.
17. Wittlinger F, et al. Risk of cholera among western and japanese travelers. J Travel Med 1995;2(3):154-8.
18. Gradon JD, et al. The fortuitous diagnosis of cholera in a two-year-old girl. Diagn Microbiol Infect Dis 1992;15(2):161-4.
19. CDC, Summary of notifiable diseases, United States, Morbidity and Mortality Weekly Report, 47, 90-2, 1999.
20. WHO, Cholera in 1995. Wkly Epidemiol Rec 1996;71(21):157-64.
21. WHO, Cholera in 1996. Wkly Epidemiol Rec 1997;72(31):229-36.
22. WHO, Cholera in 1997. Wkly Epidemiol Rec 1998;73(27):201-8.
23. WHO, Cholera, 1998. Wkly Epidemiol Rec 1999;74(31):257-64.
24. WHO, Cholera, 1999. Wkly Epidemiol Rec 2000;75(31):249-56.
25. WHO, Cholera, 2000. Wkly Epidemiol Rec 2001;76(31):233-40.
26. Sanchez JL, Taylor DN. Cholera. Lancet 1997;349(9068):1825-30.
27. Taylor DN, et al. Cholera among Americans living in Peru. Clin Infect Dis 1996;22(6):1108-9.
28. Weber JT, Levine WC, Hopkins DP, Tauxe RV. Cholera in the United States, 1965-1991: risks at home and abroad. Arch Intern Med 1994;154:551-6.
29. Ryan ET, Calderwood SB. Cholera vaccines. J Travel Med 1994;8(2):82-91.
30. Burkhardt U, Blessing J, Langbein G. Importation of cholera from Turkey. Case report of cholera acquired in Istanbul. Fortschr Med 1996;114(35-36):485-7.
31. Dalsgaard A, et al. The first case of Vibrio cholerae 0139 in Denmark. Ugeskr Laeger 1996;158(37):5169-71.
32. Gaudio PA, et al. Diarrhea among expatriate residents in Thailand: correlation between reduced campylobacter prevalence and longer duration of stay. J Travel Med 1996;3(2):77-9.
33. Lange KH, et al. Cholera in Denmark - an imported case of illness. Ugeskr Laeger 1995;157(16):2325-6.
34. Sharma TK, et al. Cholera gravis caused by Vibrio cholerae 0139, a novel, imported pathogen. Clin Infect Dis 1995;21(1):241-2.
35. Smit AA, et al. 2 Dutch travelers returning from Thailand with cholera. Ned Tijdschr Geneeskd 1994;138(17):871-3.
36. Ueda Y, et al. Bacteriological studies of traveller's diarrhoea (6). Analysis of enteropathogenic bacteria at Kansai Airport Quarantine Station from September 4th, 1994 through December 1996. Kansenshogaku Zasshi 1999;73(2):110-21.
37. Guerrant RL. Gastrointestinal infections and food poisoning. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious disease. New York: Churchill Livingstone; 1995. p. 945-62.
38. Mudur G. Drug resistant cholera in India attributed to antibiotic misuse. BMJ 2000;321(7273):1368.
39. Rakoto Alson AO, et al. Vibrio cholerae in Madagascar: study of a multiresistant strain. Arch Inst Pasteur Madagascar 2001;67(1-2):6-13.
40. Melano R, et al. New carbenicillin-hydrolyzing beta-lactamase (CARB-7) from Vibrio cholerae non-O1, non-O139 strains encoded by the VCR region of the V. cholerae genome. Antimicrob Agents Chemother 2002;46(7):2162-8.
41. Mazel D, et al. A distinctive class of integron in the Vibrio cholerae genome. Science 1998;280(5363):605-8.
42. Baranwal S, et al. Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob Agents Chemother 2002;46(8):2676-8.
43. Clemens JD, et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986;2(8499):124-7.
44. Clemens JD, et al. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis 1988;158(1):60-9.
45. van Loon FP, et al. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine 1996;14(2):162-6.
46. Sanchez JL, et al. Protective efficacy of oral whole-cell/recombinant-B- subunit cholera vaccine in Peruvian military recruits. Lancet 1994;344(8932):1273-6.
47. TRAVAX http://www.travax.scot.nhs.uk/
48. Deutsche Gesellschaft für tropenmedizin und Internationale Gesundheit e.V, http://www.dtg.mwn.de
49. CDC http://www.cdc.gov/travel/cholera.htm
50. Canada communicable disease report http://www.hc-sc.gc. ca/pphb-dgspsp/tmp-pmv/info/cholera_e.html, 1998
51. Kilhamn J, et al. Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis. Infect Immun 1998;66(8):3995-9.
52. Ortigao-de-Sampaio MB, et al. Increase in plasma viral load after oral cholera immunization of HIV-infected subjects. Aids 1998;12(14):F145-F150.
53. Eriksson K, et al. Intestinal antibody responses to oral vaccination in HIV-infected individuals. Aids 1993;7(8):1087-91.
54. Friman V, et al. Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination. Clin Exp Immunol 1994;95(2):222-6.